Clinical Trials Browser

Phase 1/2 × mobocertinib × 30 days × Clear all

NCT02716116 2026-02-25

A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer

Phase 1/2 Active not recruiting

334 enrolled 1 FDA

Carcinoma, Non-Small-Cell Lung